User profiles for Cristina Legido Quigley

Cristina Legido-Quigley

Steno Copenhagen, King's College London, Imperial College London
Verified email at kcl.ac.uk
Cited by 7526

A top‐down systems biology view of microbiome‐mammalian metabolic interactions in a mouse model

…, ME Dumas, Y Wang, C LegidoQuigley… - Molecular systems …, 2007 - embopress.org
Symbiotic gut microorganisms (microbiome) interact closely with the mammalian host's
metabolism and are important determinants of human health. Here, we decipher the complex …

Metabolic network failures in Alzheimer's disease: A biochemical road map

…, L Shen, R Casanova, S Varma, C Legido-Quigley… - Alzheimer's & …, 2017 - Elsevier
Introduction The Alzheimer's Disease Research Summits of 2012 and 2015 incorporated
experts from academia, industry, and nonprofit organizations to develop new research …

Evidence for brain glucose dysregulation in Alzheimer's disease

…, AI Levey, J Lah, NT Seyfried, C Legido-Quigley… - Alzheimer's & …, 2018 - Elsevier
Introduction It is unclear whether abnormalities in brain glucose homeostasis are associated
with Alzheimer's disease (AD) pathogenesis. Methods Within the autopsy cohort of the …

[HTML][HTML] Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study

…, R Kaddurah-Daouk, C Legido-Quigley… - PLoS …, 2018 - journals.plos.org
Background The metabolic basis of Alzheimer disease (AD) is poorly understood, and the
relationships between systemic abnormalities in metabolism and AD pathogenesis are unclear…

Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease

…, B Vellas, S Lovestone, C Legido-Quigley… - Neurobiology of …, 2014 - Elsevier
Abberant lipid metabolism is implicated in Alzheimer's disease (AD) pathophysiology, but
the connections between AD and lipid metabolic pathways are not fully understood. To …

[HTML][HTML] Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study

…, R O'Brien, J Troncoso, C Legido-Quigley… - PLoS …, 2017 - journals.plos.org
Background The metabolic basis of Alzheimer disease (AD) pathology and expression of AD
symptoms is poorly understood. Omega-3 and -6 fatty acids have previously been linked to …

[HTML][HTML] Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis

…, JF Powell, RJB Dobson, C Legido-Quigley - Alzheimer's & …, 2017 - Elsevier
Introduction The aim of this study was to (1) replicate previous associations between six blood
lipids and Alzheimer's disease (AD) (Proitsi et al 2015) and (2) identify novel associations …

Advances in capillary electrochromatography and micro‐high performance liquid chromatography monolithic columns for separation science

C LegidoQuigley, ND Marlin, V Melin, A Manz… - …, 2003 - Wiley Online Library
Over the last decade, monoliths or continuous beds have emerged as an alternative to
traditional packed‐bed columns for use in capillary electrochromatography (CEC) and micro‐high …

[HTML][HTML] Abnormal brain cholesterol homeostasis in Alzheimer's disease—a targeted metabolomic and transcriptomic study

…, DA Bennett, T Çakır, C Legido-Quigley… - npj Aging and …, 2021 - nature.com
The role of brain cholesterol metabolism in Alzheimer’s disease (AD) remains unclear.
Peripheral and brain cholesterol levels are largely independent due to the impermeability of the …

[HTML][HTML] Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease

…, H Israelsen, M Karsdal, C Legido-Quigley… - Journal of …, 2021 - Elsevier
Background & aims Alcohol is the most common cause of liver-related mortality and morbidity.
We therefore aimed to assess and compare the prognostic performance of elastography …